Willow advertises 2-4 business days for pharmacy processing followed by 2-3 days of shipping via FedEx or UPS
individual clinical response varies widely and depends on dosing, adherence, lifestyle, and concurrent health conditions
Zepbound: A Tirzepatide Option Zepbound, a once-weekly injectable, targets both GLP-1 and GIP receptors, offering the highest weight loss efficacy recorded at an average of 20.9% body weight loss
Diabetic Retinopathy Progression Some clinical trials have reported worsening diabetic retinopathy in patients using semaglutide, especially among those with long-standing diabetes, elevated baseline A1C levels, or concurrent insulin therapy
For more on how IV therapy can help specific dietary groups, read Why IV Therapy with Vitamin B12 is Essential for Vegetarians
In 2023, after a 40 percent rebate, the SHP spent $102.3 million on GLP-1s for weight loss, approximately 10 percent of the programs pharmacy expenditures